Parents in the Annville Cleona School District protest school mask mandate wgal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wgal.com Daily Mail and Mail on Sunday newspapers.
V2ACT Therapeutics™, LLC Announces FDA Clearance of an IND Application to proceed with a Phase 1/2a Study of V2ACT for the Treatment of Pancreatic Cancer
- V2ACT Therapeutics™, LLC is a joint venture of Genelux Corporation and TVAX Biomedical, Inc.
- V2ACT is a proprietary immuno-oncology modality composed of Olvi-Vec (oncolytic immunotherapy) and V-ACT (vaccine-enhanced adoptive cell therapy).
- V2ACT capitalizes on:
- Olvi-Vec as an ideal systemic immunomodulator with its excellent safety profile, favorable immune activation effects on the tumor microenvironment and well-documented anti-cancer effects on a wide range of cancers demonstrated in preclinical and phase 2 clinical studies.